The present work demonstrates that tumorigenic CD44+CD24−/low (CD24−) cells can originate from primary CD44lowCD24+ (CD24+) human mammary epithelial cells (HMECs) following their transformation with a limited number of oncogenes and cancer-associated genes. The gene discussed is CD24; the disease is cancer.